Abdulaziz Alolayan
Overview
Explore the profile of Abdulaziz Alolayan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alsultan A, Dasuqi S, Almohaizeie A, Aljutayli A, Aljamaan F, Omran R, et al.
J Clin Pharmacol
. 2023 Oct;
64(3):353-361.
PMID: 37862131
Obesity combined with critical illness might increase the risk of acquiring infections and hence mortality. In this patient population the pharmacokinetics of antimicrobials vary significantly, making antimicrobial dosing challenging. The...
2.
Alolayan A, Aldamegh A, AlKhayrat A
Case Rep Crit Care
. 2023 Mar;
2023:8530060.
PMID: 36895203
Coronavirus disease (COVID-19) is an emergency pandemic with a high mortality rate worldwide. One of its complications in children is developing multisystemic inflammatory syndrome related to cytokine storm. Anakinra is...
3.
Al Sulaiman K, Korayem G, Altebainawi A, Al Harbi S, Alissa A, Alharthi A, et al.
Crit Care
. 2022 Oct;
26(1):304.
PMID: 36192801
Background: Inhaled nitric oxide (iNO) is used as rescue therapy in patients with refractory hypoxemia due to severe COVID-19 acute respiratory distress syndrome (ARDS) despite the recommendation against the use...
4.
Al Sulaiman K, Qahtani N, Al Muqrin M, Al Dossari M, Al Wabel A, Al Sulaiman T, et al.
J Int Med Res
. 2022 Jul;
50(7):3000605221108082.
PMID: 35818158
Objective: To investigate the correlation between the ABO blood group and the risk of recurrent catheter-associated urinary tract infections (CA-UTI) and multi-drug resistant (MDR) organism reinfection in the critically ill....